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Abstract
Background—Waist circumference (WC) is a stronger predictor of colon cancer (CRC) risk than 
body mass index (BMI). However, how well change of either WC or BMI predicts risk of 
advanced colorectal neoplasia (AN) is unclear.
Aims—To determine the relationship between change in BMI and WC from early adulthood to 
later age and the risk of AN, and which change measure is a stronger predictor.
Methods—In 4,500 adults, ages 50–80, with no previous neoplasia and undergoing screening 
colonoscopy, BMI and WC at age 21 and at time of screening were reported. Changes in BMI and 
WC were defined using universal risk cutoffs. Known CRC risk factors were controlled in the 
logistic models.
Results—Overall, model statistics showed WC change (omnibus-test χ2=10.15, 2 DF, p-
value=0.006) was a statistically stronger predictor of AN than BMI change (omnibus-test χ2=5.66, 
5 DF, p-value=0.34). Independent of BMI change, participants who increased WC (OR=1.44; 95% 
CI 1.05-1.96) or maintained a high-risk WC (OR=2.50; 95% CI 1.38-4.53) at age 21 and at 
screening had an increased risk of AN compared to those with a low-risk WC. Study participants 
who were obese at age 21 and at screening had an increased risk of AN (OR=1.87; 95% CI 
1.08-3.23) compared to those who maintained a healthy BMI. Maintaining an overweight BMI or 
increasing BMI was not associated with AN.
Conclusions—Maintaining an unhealthy BMI and WC throughout adult life may increase risk 
AN. WC change may be a better predictor of AN than BMI change.
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INTRODUCTION
Colorectal cancer is a global public health problem [1], the third most common cancer and 
the third leading cause of cancer death in both men and women in the U.S. [1, 2]. In 2016, 
the American Cancer Society estimated 134,490 new cases and 49,190 colorectal cancer 
(CRC) deaths would occur [2]. Obesity is an established risk factor for CRC in both men 
and women [3–5], with a stronger link reported in men [6–8]. Epidemiological data suggests 
that 30% to 70% increased risk of CRC can be attributed to obesity [9].
Both body mass index (BMI) and waist circumference (WC) have been associated with 
increased risk of CRC and other chronic disease [10, 11]. However, WC is a better predictor 
of CRC than BMI [10], in part because WC measures visceral fat, which has been linked to 
increased risk of chronic diseases [10], After complete growth in height, often by age 21 
[12], any weight gain in adulthood results mostly in visceral fat accumulation [13, 14], 
increasing an individual’s BMI and WC. Increase in adult weight gain is associated with an 
increased risk of CRC [15, 16] and the risk stronger in men [15, 17]. Although a few studies 
have assessed the association of weight gain and risk of precancerous colorectal polyps [18, 
19] and CRC [20–26], few studies have assessed WC change and risk of CRC [27, 28], and 
to our knowledge none on advanced colorectal neoplasia (AN), the composite of colorectal 
cancer and advanced precancerous polyps. An increase or maintaining high risk adiposity 
measures over time may be a better indicator of risk for AN than cross-sectional values at 
specific points in time.
Therefore, we sought to determine the association of changes in BMI and WC from early 
(age 21) to later adulthood (time of screening) and the risk of AN, and which of the two 
dynamic measures was a better predictor of the risk of AN. As an exploratory aim we 
compared the dynamic measures of BMI and WC to their static measures at age 21 and at 
time of screening in predicting risk of AN.
METHODS
This study was conducted at Indiana University Medical Center in Indianapolis and was 
approved by the institutional review boards at Indiana University and the Richard L. 
Roudebush Veterans Affairs Medical Center, Indianapolis, Indiana.
Study population
The parent study methods have been discussed in detail elsewhere [29]. The study was 
initiated to assess the factors associated with the risk for AN. Study participants were 
eligible for the study if they were aged 50 to 80 years and were undergoing first-time 
colonoscopy screening. Participants were initially recruited from two large corporations that 
provided screening colonoscopy for their employees, retirees, and their dependents. Due to 
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saturation of screening colonoscopy through these company-based programs, additional 
recruitment was sought from Indianapolis Gastroenterology and Hepatology, the Wishard 
Memorial Hospital, Roudebush Veterans Affairs Medical Center, affiliate hospitals of 
Indiana University Medical Center; and from Margaret Mary Community Hospital in 
Batesville, IN. Participants were excluded if they had previous colorectal cancer or 
adenomatous polyps, inflammatory bowel disease, or familial or non-familial polyposis 
syndrome. Persons with a previous sigmoidoscopy or diagnostic colonoscopy were not 
excluded unless it had been performed within the last 5 or 10 years, respectively.
Eligible subjects who were already scheduled for screening colonoscopy received a letter of 
introduction describing the study along with a 12-page, 50-item self- administered 
questionnaire and a 72-inch tape measure. Participants received a follow- up call to clarify 
eligibility and answer questions about the study. The study questionnaire gathered data on a 
variety of factors: demographic variables, family history of colorectal cancer, personal 
medical history (including previous lower endoscopic procedure findings and non-
endoscopic screening test results), lifestyle habits (diet, exercise, cigarette smoking, alcohol 
use), medication use (particularly aspirin, non-steroidal anti-inflammatory drugs, and post-
menopausal hormone replacement therapy), and anthropometric measures.
Adiposity measures
Participants were asked about their weight, height, and WC history. The weight history 
question was 1) “When you were age 21, what was your approximate weight and 
approximate waist circumference?” The participants were also asked to estimate their 
current weight (without shoes) and their waist size. In addition, a tape measure and 
instructions were provided in the package for the participants to accurately record their WC 
by measuring the smallest part, above the navel, body naturally erect, and abdomen neither 
drawn in nor protruded. On the day of the colonoscopy, nursing personnel at each site 
recorded physical measures (height, weight, waist and hip circumference). There were 
strong positive correlations between measured and self-reported WC (rho=0.899, p=<.0001) 
as well as between measured and self-reported BMI (rho=0.967, p=<.0001).
BMI was calculated as a ratio of weight and height squared (kg/m2) and grouped into three 
categories: normal (<25.00), overweight (≥25.00-29.99), and obese (≥30.00) using the World 
Health Organization’s criteria [30]. In calculating BMI change, BMI at age 21 was the 
baseline BMI and was compared with BMI at Time 2 (current, i.e., time of screening). BMI 
changes were defined in 9 specific categories within three broad areas [31]: A. Maintained 
BMI: 1) Stable-Normal: having normal BMI at both time points; 2) Stable-Overweight: 
being overweight at both time points; and 3) Stable-Obese: being obese at both time points. 
B. Increased BMI from age 21 to Time 2: 4) Normal to Overweight: BMI increased from 
normal to overweight, 5) Normal to Obese: BMI increased from normal to obese; and 6) 
Overweight to Obese: BMI increased from overweight to obese. C. Reduced BMI from 7) 
Overweight to Normal; 8) Obese to Overweight and 9) Obese to Normal from age 21 to 
Time 2.
Self-reported WC at age 21 and WC measured at screening (Time 2) were categorized into 
two risk groups using recommended international sex specific cutoffs: low risk (females <35 
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inches and males <40 inches) and high risk (≥35 inches for females and ≥40 inches for 
males) [32]. WC change was categorized as follows: 1) Stable-low risk: having a low risk 
WC at age 21 and screening; 2) High-low risk: having a high risk WC at age 21 but low risk 
at screening; 3) Low-high risk: having a low risk WC at age 21 and high risk WC at 
screening and 4) Stable-high risk: having a high risk WC at both time points.
Outcome Ascertainment
Colonoscopy and pathology reports were reviewed and coded by trained personnel who 
were blinded to survey information. Results of the colonoscopies were coded based on the 
most advanced histological findings. Advanced precancerous polyps were defined as an 
adenoma ≥1 cm or one with villous histology or high-grade dysplasia.
Statistical Analysis
Descriptive statistics comparing the characteristics of those with and without AN were 
performed. Pearson chi-square tests and two-sided t-tests were performed to compare the 
distributions and means of covariates and exposures of interest (BMI and WC) by AN status. 
Multiple logistic regression analysis was used to estimate the risk of AN based on changes 
in BMI and changes in WC. Three separate adjusted models were assessed: 1) BMI change 
as the risk factor; 2) WC change as the risk factor; and 3) both BMI change and WC change 
as the risk factors. Very few participants reduced their BMI (n=11) or reduced their WC 
(n=26), therefore, these individual cases were excluded from the analytical dataset due to the 
low statistical power of detecting a true effect. The exclusions of these two categories led to 
fewer BMI change and WC change categories. Within two broad BMI change categories 
(Maintaining and Increasing BMI), six specific risk categories were used in the models: 1) 
stable-normal, 2) stable-overweight, 3) stable-obese; increase from 4) normal to obese, 5) 
normal to overweight and 6) overweight to obese were used in the models with stable-
normal as the reference category. For WC change, three risk categories were used, 1) stable-
low, 2) low-high and 3) stable-high risk, with stable-low risk WC as the reference category.
Several known factors for CRC were included in the logistic regression model: age, race, 
gender, education, smoking, NSAID use, physical activity, alcohol intake, family history, red 
meat intake, vegetable intake, and estrogen use in women [33]. These factors were assessed 
as confounding variables by comparing the crude and adjusted OR of the BMI and WC.
To assess which adiposity measure (BMI change or WC change) was statistically 
significantly better at predicting risk of AN, we assessed the model statistics when each 
adiposity change variable was in the model alone (with covariates) and also when both BMI 
change and WC change were simultaneously considered in the model. Since BMI and WC 
are related, we assessed collinearity of BMI change and WC change. The collinearity 
diagnostics did not indicate that the correlations (rho=0.39, p-value <.0001) of the two 
measures were affecting the conclusions drawn from the analysis. The model statistics of 
interest were Akaike Information Criterion (AIC), c-statistic, the Type 3 (i.e., adjusted for 
other variables in the model) omnibus likelihood ratio test for the variable of interest, and the 
Hosmer and Lemeshow goodness-of-fit test [34]. Models with lower AIC, higher c-statistic, 
and lower p-value were considered better models statistically [34].
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All statistical analyses were performed using SAS for WINDOWS software, version 9.4. All 
tests were two-sided and p-values of <0.05 were considered statistically significant.
RESULTS
Descriptive characteristics of the participants are summarized in Table 1. The mean age of 
the participants was 57.3 (± 6.8) years; 52% were women. Most of the study participants 
were non-Hispanic white and had high levels of education. Those with AN were more likely 
to be, males, to report a higher intake of red meat, and lower rates of vegetable intake as well 
as higher rates of, alcohol use, cigarette smoking, physical inactivity and a family history of 
colorectal cancer.
Table 2 shows the results of logistic regression analyses assessing the relationship between 
change in BMI and change in WC on the risk of AN. Being obese at age 21 and at the 
current age (stable-obese), compared to stable-normal, was associated with increased risk of 
AN (OR=1.87). Neither increasing BMI nor stable-overweight between age 21 and current 
age was associated with an increased risk of AN. All BMI change categories were not 
significant when WC change was included in the model. Regarding WC, when WC change 
was assessed alone in the model, only stable-high risk WC was significantly associated with 
a two-fold increased risk of AN (OR=2.16). However, when BMI change was controlled for 
in the model, an increase in WC from low to high risk (OR=1.44) and a stronger association 
of stable-high risk WC (OR=2.50) were associated with an increased risk of AN.
Model statistics that summarize the overall impact of including WC change alone, BMI 
change alone, and both variables of interest, on the overall model are presented in Table 3. 
All models (adjusted for confounders) were similar in discrimination and goodness-of-fit. As 
shown by the Hosmer and Lemeshow goodness of fit measures [34], the data fit well in 
predicting risk of AN. Furthermore, as indicated by the c-statistic, all models had a high 
(76%) and comparable ability to discriminate those with versus without AN. For all models, 
the likelihood ratio tests for significance of the overall model were significant, indicating 
that the set of covariates in the model, along with BMI and/or WC, were a strong set of 
predictors of AN. As expected, the base model (with covariates only) had the largest AIC. 
The lower AIC for the other models indicates that the model was improved at predicting risk 
of AN when BMI change or WC change were added in the model. The omnibus test for the 
variables of interest showed that WC change (p-value=.004) and not BMI change (p-value=.
11) predicted risk of AN. And when both variables were included in the model, only the 
omnibus test of WC change was significant (p=.006); BMI change was not significant (p=.
34)
In our exploratory aim, assessing whether dynamic or static measures were better at 
predicting risk of AN, we found that those models with dynamic measures of BMI or WC 
compared to those with static measures did not differ substantially in discriminating those 
with versus those without AN (Table 4). For BMI, the static measure of BMI at age 21 
(omnibus-test χ2=9.53, 2 DF, p-value=0.009; obese vs. normal OR=1.91, 95% CI 1.22-3.00, 
overweight vs. normal OR=1.27, 95% CI 0.96-1.67), but not current BMI (omnibus-test 
χ2=0.22, 2 DF, p-value=0.89; obese vs. normal OR=1.07, 95% CI 0.79-1.45; overweight vs 
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normal OR=1.02, 95% CI 0.76 vs. 1.37), was better than dynamic BMI (p=0.11) at 
predicting risk of AN. All WC measures, dynamic and static, significantly predicted risk of 
AN. Interestingly, WC at age 21 (omnibus-test χ2=7.53, 2 DF, p-value=0.006; high vs. low 
risk OR=1.85, 95% CI 1.19-2.86) was a stronger predictor of risk for AN than current WC 
(omnibus-test χ2 = 4.60, 2 DF, p-value=0.03; high vs low risk OR=1.29, 95% CI 1.02-1.63).
DISCUSSION
In this study, we observed a positive association of increases in WC from early to later 
adulthood with risk of AN. Maintaining an obese status and a high risk WC over time were 
also associated with increased risk of AN. Overall, WC change appeared to be a stronger 
predictor of AN compared to BMI change. To our knowledge, no other study has examined 
change using risk categories, and none has examined the association of BMI change and WC 
change with the risk of AN.
Among the few studies conducted on the association between weight change and AN, 
weight gain was found to be associated with increased risk of AN; this is similar to the 
findings of our study. Our study differed from other studies since we assessed change using 
obesity risk categories while other studies assessed weight gain as an absolute value in 
kilograms or pounds. Weight gain from age 18 [18] or 10 years prior to screening [19] were 
associated with a two-fold increased risk of colon adenomas. We conducted a sensitivity 
analysis using similar methods and actual weight difference, but did not find any association 
with risk for AN (OR= 1.0; 95% CI 0.70-1.36 Quartile 4 vs. Quartile 1), data not shown. 
Also, since AN is the combination of colorectal cancer (CRC) and advanced precancerous 
polyps, we reviewed studies assessing weight gain and CRC and found conflicting results 
for the association of weight gain and CRC. In some studies, weight increase has been 
associated with increased risk for colorectal cancer [24, 26, 35] while others have shown 
increased risk in men but not women [21–23].
Waist circumference is considered a reliable surrogate of visceral obesity because it is more 
closely related to obesity-associated cardio metabolic disorders [10, 36]. Few studies have 
assessed WC change and risk of CRC. One study found increase in WC to be positively 
associated with CRC risk in men but not women [28], and another found no association [27]. 
To our knowledge, this may be the first study to examine the association of WC change and 
risk of AN, the composite of advanced precancerous polyps and colorectal cancer. Our 
findings indicate that participants who at age 21 and later at screening had WC equal to or 
larger than the recommended maximum value (women 35 inches and men 40 inches) had an 
increased risk of AN. In addition, those whose WC increased from early to late adulthood 
had an increased risk of AN, but only when their change in BMI was controlled in the 
model. Overall, WC measured as a dynamic or static value was found to be a better predictor 
of risk for AN compared to BMI measures. This is consistent with other studies that have 
shown WC to be a better predictor of diabetes [37]and cancer [10]. Even when BMI change 
was accounted for, WC change emerged as an independent predictor of AN. These results 
indicate that perhaps WC change provides a unique prediction of AN separate from the 
characteristics that WC and BMI share in common.
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The findings of this study are strengthened by the concurrent assessment of both WC and 
BMI in relation to risk of AN. In adults, WC is a better predictor of obesity-related health 
risk than BMI [38], however, a combination of both factors is a better estimate of health risk 
than either factor alone [39]. This is because health risk increases from normal weight 
through obese BMI categories, but within each BMI category, those with higher WC values 
have a greater health risk than those with normal WC values [40]. Although we did not 
create a single variable that combined both WC and BMI, we adjusted for the effect of the 
other in the regression models to better understand the unique contribution of each adiposity 
measure on the risk of AN. Additional strengths of the study include the large sample size 
(n=4,500) and weight history assessment. The findings of this study may be generalizable to 
the non-Hispanic white population who were a majority in the study. Although a majority of 
the participants were non-Hispanic white, the obesity rates in our study are comparable to 
the national age-adjusted obesity rates (35.9% vs 34.9%) [41].
Study limitations are those inherent in an observational study. There was the possibility of 
intentional and unintentional errors for self-reported WC as well as height and weight used 
to calculate BMI. However, self-reported and measured weights have previously been 
reported to be highly correlated [42, 43]. The associations were modeled based on self-
reported historical WC, weight and height, which may lead to a recall misclassification of 
WC and BMI. However, it is likely that the same amount of misclassification error (non-
differential) occurred in those with and without AN and perhaps attenuated the results. Also, 
we were unable to assess the impact of BMI decrease on risk of AN because the number of 
subjects were too small. Nonetheless, we adjusted several of the known colorectal cancer 
risk factors in an attempt to isolate the specific impact of adiposity measures on AN. Past 
studies have revealed there may be gender differences in the association of BMI, WC and 
the risk of CRC [15, 17], although we adjusted for the effect of gender in all our regression 
models we did not assess the relationship of WC Change, BMI Change and risk of AN for 
men and women strata. Finally, our assessment was based on neoplasia diagnosis rather than 
incidence. Neoplasia may have developed a considerable amount of time before the 
diagnosis, and this may lead to errors in estimating the period at risk. Due to these 
limitations, causal relationships cannot be drawn from this study.
In conclusion, our results support previous findings that adiposity is a risk factor for 
advanced neoplasia of the colon and rectum, with WC change being an independent and 
stronger predictor of AN compared to BMI change. The results emphasize the importance of 
maintaining a healthy BMI and WC throughout adult life which may prevent AN. Although 
the effect on risk for AN associated with BMI and WC dynamic measures did not differ 
substantially from that of their static values, dynamic measures may be useful in identifying 
and stratifying risk for AN. Weight gain, expressed in terms of movement between BMI or 
WC categories may be more practical and useful in clinical practice than absolute weight 
gain, however, this should be determined in subsequent studies. Health care providers may 
use the findings as a prevention strategy for colorectal cancer when counseling patients, in 
line with the American Society of Clinical Oncology’s prioritization of educating providers 
and patients on the role of energy balance as a strategy to reduce the impact of obesity on 
cancer [44]. Long-term prospective studies are needed to validate our findings and to explore 
the association of changes in BMI and WC and the risk of AN. Finally, in our exploratory 
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aim, both BMI and WC at age 21 significantly predicted risk of AN, an aim worth further 
exploration. These preliminary results support emerging evidence that early life adiposity 
affects the risk of colorectal cancer many decades later [45].
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Table 1
Characteristics of Study Subjects by Advanced Neoplasia Status
Advanced
Neoplasia
(n=410)
No-Advanced
Neoplasia
(n=4,090)
p value
Mean (SD) t value
Age (year) 61.4 (9.0) 56.9 (6.3) 568.7 <.0001
Pack years 20.8 (26.1) 8.7 (16.6) 36.5 <.0001
Vegetable intake-weekly 15.1 (8.2) 15.9 (7.5) 140.0 0.05
Red meat intake-weekly 5.1 (3.0) 4.1 (2.5) 111.3 <.0001
n (%) X2 [DF]
Gender
  Male 250 (61.0) 1,928 (47.1) 28.6 [1] <.0001
  Female 160 (39.0) 2,162 (52.9)
Race
  Non-Hispanic White 358 (87.3) 3884 (95.0) 76.8 [2] <.0001
  Non-Hispanic Black 44 (10.7) 106 (2.6)
  Other 8 (1.9) 100 (2.4)
Education
  High School Education 152 (37.1) 1060 (26.0) 47.8 [3] <.0001
  Trade/Vocational School 62 (15.1) 401 (9.8)
  College Education 141 (34.4) 1682 (41.2)
  Postgraduate 55 (13.4) 940 (23.0)
*Alcohol Use
  No problem drinking 323 (78.8) 3492 (85.4) 12.9 [1] 0.0003
  Problem drinking 87 (21.2) 595 (14.6)
†Aspirin-NSAID intake
  Low 258 (62.9) 2649 (64.8) 6.6 [2] 0.04
  Medium 46 (11.2) 581 (14.2)
  High 106 (25.9) 860 (21.0)
Estrogen (Females)
  No 37 (23.1) 918 (42.3) 23.3 [1] <.0001
  Yes 123 (76.9) 1238 (57.4)
Exercise
  0-<2 hrs./week 239 (58.3) 1743 (42.6) 32.6 [2] <.0001
  2 to <4hrs./week 153 (37.3) 2054 (50.2)
  >4 hrs./week 9 (2.2) 102 (2.5)
Family History of Colorectal Cancer
  Yes 55 (13.4) 372 (9.1) 8.1 [1] 0.004
  No 355 (86.6) 3718 (90.0)
*
Problem drinking is defined as having ≥11 or ≥6 drinks/week for males and females respectively.
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†Aspirin-NSAID intake is defined as, Low ≤1/month for 1–5 years or 1-/month for 6–10 years; Medium 1–7/month for 11–20 years or 2–5/week 
for 6–10 years or 1–7/month for ≥20yrs; and High ≥2 per week for ≥10 years or daily for 6+ years.
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Table 2
Association of BMI Change, Waist Circumference Change and risk of Advanced Neoplasia
Change from Age 21 to Current
Distribution
n (%)
Models a* Model b*
WC change and BMI change in
separate models
WC change and BMI
change in model together
AN No AN
BMI Change
  Stable-Normal BMI 81 (21.0) 1130 (28.1) Reference Reference
  Stable-Overweight 37 (9.6) 246 (6.1) 1.54 (0.97–2.45) 1.34 (0.83–2.16)
  Stable-Obese 23 (6.0) 132 (3.3) 1.87 (1.08–3.23) 1.01 (0.51–1.99)
  Normal to Obese 80 (20.7) 707 (17.6) 1.14 (0.80–1.62) 0.86 (0.57–1.32)
  Normal to Overweight 113 (29.3) 1328 (33.1) 1.00 (0.72–1.38) 0.89 (0.64–1.25)
  Overweight to Obese 52 (13.5) 473 (11.8) 1.04 (0.69–1.57) 0.74 (0.46–1.19)
Waist Circumference change
  Stable-Low risk 199 (49.6) 2408 (59.7) Reference Reference
  Low-High risk 175 (43.6) 1442 (35.8) 1.23 (0.97–1.57) 1.44 (1.05–1.96)
  Stable-High risk 27 (6.7) 182 (4.5) 2.16 (1.35–3.46) 2.50 (1.38–4.53)
The table shows results of several analyses conducted to assess the association of individual and combined measurements and risk of advanced 
colorectal neoplasia. All logistic regression models were adjusted for age (continuous), race (non-Hispanic white, non-Hispanic black, Other), 
gender (male vs female), and education (high school, trade/vocational, college education and postgraduate), family history of colon cancer (yes/no), 
smoking (pack years), exercise, alcohol use (yes/no), red meat intake (daily), vegetable intake (daily), use of aspirin or other NSAIDs and estrogen 
use (yes/no).
*
Bolded Odds ratios and 95% CI indicate estimates that are statistically significant.
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